Hafnarfjordur, Iceland; also reported as based in Zug, Switzerland; a major generic drug company; had acquired Biopartners; was acquired by Watson for $5.5 billion in fall 2012, renamed Watson, with the merged company the 3rd largest generic drug company behind Teva and Sandoz
